Status:

COMPLETED

Impact of Aerobic Exercise on Asthma Morbidity

Lead Sponsor:

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Collaborating Sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Jewish General Hospital

Conditions:

Asthma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Asthma is a chronic disorder of the airways primarily driven by increased airway inflammation, and is an escalating medical problem in Canada. For example, between 1994 and 2001 there was a 40% increa...

Detailed Description

Introduction: Asthma is a chronic respiratory disorder primarily driven by increased airway inflammation. It is one of the most prevalent chronic conditions affecting Canadians. It is the most common ...

Eligibility Criteria

Inclusion

  • Physician diagnosed asthma (confirmed by medical record evidence of bronchodilator reversibility of 12% or a minimum of 180 cc or PC20 methacholine \<= 16 mg/ml)
  • Sedentary (currently do less than 60 min of structured / planned physical activity per week)
  • Taking at least 250 mg fluticasone equivalent per day
  • On stable dose and regimen of asthma medications
  • Mild to moderate symptomatic asthma as defined by an Asthma Control Questionnaire score of 1.25 or greater.

Exclusion

  • Diagnosed co-morbid disease for which there are already established exercise guidelines i.e., cardiac disease or COPD
  • Any other medical condition that confers greater illness morbidity than asthma (e.g., active cancer) which will confirmed by physician review
  • FEV1 lower than 60% of predicted
  • Incapable of exercising
  • A BMI \> 30 kg/m2
  • Unable to speak or understand either French or English
  • \<18 years of age
  • Patients who are currently pregnant or intend to become pregnant over the course of the study.

Key Trial Info

Start Date :

January 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT00953342

Start Date

January 1 2010

End Date

August 1 2014

Last Update

February 12 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Montreal Chest Institute

Montreal, Quebec, Canada, H2X 2P4

2

Jewish General Hospital

Montreal, Quebec, Canada, H3T 1E2

3

Hopital du Sacre-Coeur de Montreal

Montreal, Quebec, Canada, H4J 1C5